Cargando…

Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels

Type 2 diabetes mellitus (T2DM) constitutes a major portion of Jordan’s disease burden, and incidence rates are rising at a rapid rate. Due to variability in the drug’s response between ethnic groups, it is imperative that the pharmacogenetics of metformin be investigated in the Jordanian population...

Descripción completa

Detalles Bibliográficos
Autores principales:	AL-Eitan, Laith N., Almomani, Basima A., Nassar, Ahmad M., Elsaqa, Barakat Z., Saadeh, Nesreen A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6462993/ https://www.ncbi.nlm.nih.gov/pubmed/30934600 http://dx.doi.org/10.3390/jpm9010017

Ejemplares similares

Association of SLC22A1, SLC22A2, SLC47A1, and SLC47A2 Polymorphisms with Metformin Efficacy in Type 2 Diabetic Patients
por: Chen, Peixian, et al.
Publicado: (2022)

The influence of metformin transporter gene SLC22A1 and SLC47A1 variants on steady-state pharmacokinetics and glycemic response
por: Ningrum, Vitarani Dwi Ananda, et al.
Publicado: (2022)

Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
por: Wang, Li, et al.
Publicado: (2013)

Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
por: Gorecki, Matthias, et al.
Publicado: (2020)

Evidence for the association of the SLC22A4 and SLC22A5 genes with Type 1 Diabetes: a case control study
por: Santiago, Jose Luis, et al.
Publicado: (2006)

Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
por: Brecht, Karin, et al.
Publicado: (2020)

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
por: Jaruskova, Monika, et al.
Publicado: (2017)

Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance
por: Heise, Michael, et al.
Publicado: (2012)

Genetic Heterogeneity of SLC22 Family of Transporters in Drug Disposition
por: Lozano, Elisa, et al.
Publicado: (2018)

Impact of ATM and SLC22A1 Polymorphisms on Therapeutic Response to Metformin in Iranian Diabetic Patients
por: Shokri, Fazlollah, et al.
Publicado: (2016)

Interaction of rs316019 variants of SLC22A2 with metformin and other drugs- an in silico analysis
por: Sajib, Abu Ashfaqur, et al.
Publicado: (2018)

Amplicon targeted resequencing for SLC2A9 and SLC22A12 identified novel mutations in hypouricemia subjects
por: Zhou, Zhaowei, et al.
Publicado: (2019)

Interactions of 172 plant extracts with human organic anion transporter 1 (SLC22A6) and 3 (SLC22A8): a study on herb-drug interactions
por: Lu, Hang, et al.
Publicado: (2017)

Functional Characterization of Rare Variants in OAT1/SLC22A6 and OAT3/SLC22A8 Urate Transporters Identified in a Gout and Hyperuricemia Cohort
por: Vávra, Jiří, et al.
Publicado: (2022)

Active Hydrophilic Components of the Medicinal Herb Salvia miltiorrhiza (Danshen) Potently Inhibit Organic Anion Transporters 1 (Slc22a6) and 3 (Slc22a8)
por: Wang, Li, et al.
Publicado: (2012)

The Impacts of SLC22A1 rs594709 and SLC47A1 rs2289669 Polymorphisms on Metformin Therapeutic Efficacy in Chinese Type 2 Diabetes Patients
por: Xiao, Di, et al.
Publicado: (2016)

Reduced-Function SLC22A1 Polymorphisms Encoding Organic Cation Transporter 1 and Glycemic Response to Metformin: A GoDARTS Study
por: Zhou, Kaixin, et al.
Publicado: (2009)

Characterization of Exosomal SLC22A5 (OCTN2) carnitine transporter
por: Console, Lara, et al.
Publicado: (2018)

Investigation of the SLC22A23 gene in laryngeal squamous cell carcinoma
por: Ekizoglu, Seda, et al.
Publicado: (2018)

Genetic variants in SLC22A3 contribute to the susceptibility to colorectal cancer
por: Ren, Anjing, et al.
Publicado: (2019)

Introduction of Organic Anion Transporters (SLC22A) and a Regulatory Mechanism by Caveolins
por: Lee, Woon Kyu, et al.
Publicado: (2006)

Effect of MEF2A and SLC22A3-LPAL2-LPA gene polymorphisms on warfarin sensitivity and responsiveness in Jordanian cardiovascular patients
por: AL-Eitan, Laith N., et al.
Publicado: (2023)

Genetic and Epigenetic Regulation of the Organic Cation Transporter 3, SLC22A3
por: Chen, Ligong, et al.
Publicado: (2012)

Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter
por: Moss, Darren M., et al.
Publicado: (2015)

Polymorphisms of SLC22A9 (hOAT7) in Korean Females with Osteoporosis
por: Ahn, Seong Kyu, et al.
Publicado: (2015)

Mutations in SLC25A22: hyperprolinaemia, vacuolated fibroblasts and presentation with developmental delay
por: Reid, Emma S., et al.
Publicado: (2017)

Contribution of SLC22A12 on hypouricemia and its clinical significance for screening purposes
por: Cha, Do Hyeon, et al.
Publicado: (2019)

Effect of Cholesterol on the Organic Cation Transporter OCTN1 (SLC22A4)
por: Pochini, Lorena, et al.
Publicado: (2020)

An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer
por: Wei, Jianming, et al.
Publicado: (2020)

Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
por: Yee, Sook Wah, et al.
Publicado: (2023)

Illuminating the Function of the Orphan Transporter, SLC22A10 in Humans and Other Primates
por: Yee, Sook Wah, et al.
Publicado: (2023)

Evaluation of the Influence of Genetic Variants of SLC2A9 (GLUT9) and SLC22A12 (URAT1) on the Development of Hyperuricemia and Gout
por: Pavelcova, Katerina, et al.
Publicado: (2020)

A report of a pedigree with compound heterozygous mutations in the SLC22A5 gene
por: Zhou, Yunguo, et al.
Publicado: (2023)

Maternal Primary Carnitine Deficiency and a Novel Solute Carrier Family 22 Member 5 (SLC22A5) Mutation
por: Jakoby, Michael, et al.
Publicado: (2021)

The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients
por: Noguera-Uclés, José Francisco, et al.
Publicado: (2020)

Identification of SLC22A5 Gene Mutation in a Family with Carnitine Uptake Defect
por: Mutlu-Albayrak, Hatice, et al.
Publicado: (2015)

Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer
por: Jung, Yeonjoo, et al.
Publicado: (2015)

Phylogenetic, syntenic, and tissue expression analysis of slc22 genes in zebrafish (Danio rerio)
por: Mihaljevic, Ivan, et al.
Publicado: (2016)

SLC22 Transporters in the Fly Renal System Regulate Response to Oxidative Stress In Vivo
por: Zhang, Patrick, et al.
Publicado: (2021)

Organic solute carrier 22 (SLC22) family: Potential for interactions with food, herbal/dietary supplements, endogenous compounds, and drugs
por: Lai, Raymond E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6uo1fhjevksalauknisji764ql